Webinar. Deciphering epitranscriptomics: The importance of RNA modifications and RNA-binding proteins in disease – Now Complimentary on Demand


In case you missed this live, online educational seminar, “Deciphering epitranscriptomics: The importance of RNA modifications and RNA-binding proteins in disease” presented by Eclipse Bio co-founder Dr. Gene Yeo (Professor, UCSD) we wanted to let you know that it is available in Science Magazine’s complimentary on-demand archive.

You can access this archive to watch the webinar at any time.

For more information and access to the archive, go to:

About This Webinar

Epitranscriptomics refers to changes in an organism’s cells resulting from posttranscriptional modification of cellular RNA. RNA-binding proteins (RBPs) play a crucial role these posttranscriptional modifications and also support several cellular processes necessary for maintaining RNA homeostasis. Uncovering the mechanisms underlying RNA modifications and RBP function are emerging frontiers in medicine that take the study of gene regulation a step beyond epigenetics. Recent research has identified over 100 distinct posttranscriptional RNA modifications. These modifications are hypothesized to have roles beyond simply fine-tuning the structure and function of RNA, and studies have linked them to various disease syndromes. Similarly, perturbations in the function of RBPs may disrupt RNA processing, thereby implicating them in the pathogenesis of several disease states.

During the webinar, viewers will:

• Gain an understanding of the scope and mechanism of RNA modifications and RBP functions
• Learn more about how RNA modifications and RBPs may be involved in the development of disease states
• Hear about different approaches used to uncover mechanisms underlying RNA modifications and RBP function.


Chuan He, Ph.D.
University of Chicago
Chicago, IL
Eugene Yeo, Ph.D.
University of California San Diego
San Diego, CA

Register at:

Questions? E-mail: webinar@aaas.org.

Produced by the Science/AAAS Custom Publishing Office and sponsored by Cell Signaling Technology.